Issue 5/2017
Content (15 Articles)
Myeloproliferative Neoplasms (B Stein, Section Editor)
Approach to MPN Symptom Assessment
Holly Geyer, Ruben A. Mesa
Myeloproliferative Neoplasms (B Stein, Section Editor)
Risk Factors for and Management of MPN-Associated Bleeding and Thrombosis
Karlyn Martin
Myeloproliferative Neoplasms (B Stein, Section Editor)
Prognostication in Philadelphia Chromosome Negative Myeloproliferative Neoplasms: a Review of the Recent Literature
Amy Zhou, Amber Afzal, Stephen T. Oh
Myeloproliferative Neoplasms (B Stein, Section Editor)
Contemporary Use of Interferon Therapy in the Myeloproliferative Neoplasms
Charles Elliott Foucar, Brady Lee Stein
Myeloproliferative Neoplasms (B Stein, Section Editor)
Chronic Myeloid Leukemia—the Promise of Tyrosine Kinase Inhibitor Discontinuation
Ravi Kishore Narra, Kathryn E. Flynn, Ehab Atallah
Myeloproliferative Neoplasms (B Stein, Section Editor)
Molecular Pathogenesis of Myeloproliferative Neoplasms: Influence of Age and Gender
Jeffrey Patterson-Fortin, Alison R. Moliterno
Myeloproliferative Neoplasms (B Stein, Section Editor)
Recent Progress in Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia
Kim-Hien T. Dao, Jeffrey W. Tyner, Jason Gotlib
Myeloproliferative Neoplasms (B Stein, Section Editor)
Familial MPN Predisposition
Tsewang Tashi, Sabina Swierczek, Josef T. Prchal
Myelodysplastic Syndromes (M Savona, Section Editor)
Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics
Aaron C. Shaver, Adam C. Seegmiller
Myelodysplastic Syndromes (M Savona, Section Editor)
Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times
Sagar S. Patel, Aaron T. Gerds
Myelodysplastic Syndromes (M Savona, Section Editor)
Molecular Data and the IPSS-R: How Mutational Burden Can Affect Prognostication in MDS
Aziz Nazha, Rafael Bejar
Myelodysplastic Syndromes (M Savona, Section Editor)
Therapy for Chronic Myelomonocytic Leukemia in a New Era
Tamara K. Moyo, Michael R. Savona
Open Access
Myelodysplastic Syndromes (M Savona, Section Editor)
Computational Modeling and Treatment Identification in the Myelodysplastic Syndromes
Leylah M. Drusbosky, Christopher R. Cogle
CART and Immunotherapy (M Ruella, Section Editor)
Immune Dysfunction in Non-Hodgkin Lymphoma: Avenues for New Immunotherapy-Based Strategies
Lorenzo Falchi
Chronic Myeloid Leukemias (J Pinilla-Ibarz, Section Editor)
Minimal Residual Disease Eradication in CML: Does It Really Matter?
Srinivas K. Tantravahi, Raga S. Guthula, Thomas O’Hare, Michael W. Deininger